Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why would there be a source for a question?
Also, you know there is no source.
Need some of those licensing agreements.
We know Leo can buy stuff with no ROI and let other people do interesting preclinical work that doesn't translate into clinical results.
It's been 8 years Leo! Money in, not money out for a change!
Another Monday with no news.
Get off the golf course and back to the negotiating table Leo! We need some deals!
Nice. Dad has it handled.
Had Brilacidin shown efficacy in the COVID trial, we would be gearing up for a combo trial with Remdesivir so that Gilead could neutralize the Brilacidin threat through partnership/buyout.
Brilacidin failed the trial which bought Gilead another year or two at the buffet going solo.
Treatment isn't the goal. The government likes COVID and likes big pharma donor drugs.
You personally know more than three people who are triple vaxxed that were hospitalized from COVID and at least three of them have died due to COVID?
Come on man, you're pulling our chains.
I think if we get news good enough to take us to $0.15 we will fly right passed it.
No reason for us to be valued at $20M or $60M. Much more or much less.
Well that's true if you want the stock price to go up.
The company is running just fine for Leo though. With all the money they raised the past year he can ride this job to and through retirement. The only one who can fire him is himself.
We've unfortunately been reading articles like these for about eight years here.
How many dollars have been offered up by any authority in the world to help Brilacidin through an antimicrobial phase 3 trial? Zero.
Right. The point being that their potentially promising preclinical COVID data is not on display in the shadow of a phase 2 COVID trial failure.
Did STI-1558 fail a phase 2 trial against COVID?
I said the value of Brilacidin's further pre-clinical work against COVID is severely diminished due to the phase 2 trials failure against COVID in the clinic.
I'm not incorrect as the market is valuing the entire pipeline including all COVID uses at $10M over cash. I would call that severely diminished value.
If STI-1558 has not failed a phase 2 against COVID yet, then it may enjoy some future hope valuation as a result of these preclinical results that Brilacidin will/is not.
A nice secondary endpoint release may change that.
Let's hope it's as accurate as the supercomputer that said Brilacidin was the Bee's knees of COVID treatments.
I feel that without some brighter secondary data points, the value of all of this preclinical antiviral work has been severely diminished by the COVID trial failure.
Its great that Brilacidin can kill tons of stuff in vitro, but if we can't administer an effective dose in the clinic what good is it?
Why?
Call all the anti-viral stuff in addition to COVID a complete flop. The leaves B-OM, B-UC, and Kevetrin.
Anyone that liked pipeline in November 2019 when the company had about $700K cash and $7M in liabilities must surely like it now that the company has $10M in cash and $5M in liabilities?
Seems like we're in a much better position cash wise than two years ago.
$0.022 is roughly valuing the company at cash holdings. You'd have to assume the pipeline has no value at all to get down to two pennies.
The entire pipeline is already discounted to B-UP levels of worthless. IPIX is very undervalued right now by even the most conservative measures if its not a complete fraud.
Don't be so harsh. Leo's IPIX holdings were worth $60M at one point. Now worth about $600K.
He really should have cashed out when Mako told him to. That $379M Ocata buyout that we all sneered at back in 2015 is looking pretty good now.
I bet Leo would walk if he could get that for a $15M payout.
Long long time.
Leo could pay off all the company liabilities and still have enough to pay his salary for 10 years. The IPIX pension system is far more solid than most government pensions.
Some would like to think he's helping out loyal shareholders.
Telling them there is news coming on the blog/email without divulging anything material.
Hopefully this is an encrypted message from Leo that good news is coming and you should load the boat at $0.04.
Or it might be an encrypted message that the secondary data is bad and you should get $0.04 for your shares while you can.
Or it might be an encrypted message that the secondary analysis is complete and sitting on his desk so he can look at it when he gets back from Boca and release the news officially...shortly.
It's anyone's guess. We'll see what comes.
Fingers crossed for a Gilead deal.
Just looking for $0.5153. Will be very happy.
I guess it was also posted on the blog
http://www.ipharminc.com/new-blog
but it was not a PR so it doesn't show up there.
Always have to check four places every day to ensure you don't miss out on IPIX news:
1. Get on the Email DL.
2. Check the blog: http://www.ipharminc.com/new-blog
3. Check the PRs: http://www.ipharminc.com/press-release
4. Check the SEC: https://www.sec.gov/edgar/browse/?CIK=1355250
Information could be disseminated through any/all of those channels.
Gmail continually changes IPIX emails to Promotional every month or so for me. They must know something I don't. Be sure to enforce those filters.
Please be right.
Email. Only for true longs in the fan club. You can sign up at the website.
I've seen enough promising preclinical data. We have a half dozen or more viruses slain in the test tube.
Show me that secondary data and compassionate use data.
I've been here for seven years and running of promises. Time for some delivery.
Well....we had words from the company. Not really any news. They simply said news is coming shortly.
Yeah but he might be willing to sell for $1 now. This is quite a pipeline for a BP with lobbying muscle to snag for under $500M.
We're really ripe for partnership at this point.
1. We're not bankrupt. $10M in cash with a payroll around $1M/year.
2. We can't really raise more funds on our own.
3. We have at least two pipeline assets ready to move forward. Possibly four counting Kevetrin and any antiviral/bacterial indications.
4. Leo isn't 55 anymore. At 62 it's time to set aside delusions of being the next Regeneron and sign some deals to secure his family's future.
$100M upfront and all Brilacidin development costs in exchange for a 8% royalty?
Then we can take that and swing for the fences on Kevetrin.
Or its massive invisible naked shorts just covering at their leisure.
Nothing fancy...just a nice little $200M-300M buyout would do wonders for my portfolio.
Leo's too.
Go IPIX!
This was nearly two years ago with no further mention of it.
$0.022 values us at cash (ignoring liabilities). Most of the liabilities are owed internally so if there is any actual value to the pipeline, it's in Leo's interest due to his number of shares to not have the company die.
We're getting pretty close to that at $0.038. Subtracting working capital, the market is valuing future potential in the company at around $8M over cash.
Keep in mind a $50M buyout results in a share price of $0.11. That's a pretty low bar if this isn't a complete fraud. There comes a point where IPIX becomes a screaming buy for a gambler and we're just about at that point.
And if Leo can actaully sign a crappy but substantive partnership on B-OM..something like $10M upfront and phase 3 costs covered with an 8% royalty...we fly high.
Literally begging for crumbs compared to what other preclinical companies routinely sign for their assets.
I think once Leo let's go of his ego we can sign the deals and get on our way.
I'll be grabbing another 100K at $0.02 and another 100K at $0.01.
I still feel this company will be bought for $50M or more.
I'd rather us partner some of our supposed assets like every other company does.
If we ever recover into some entity that needs a better website domain name I'll be very thankful.
Having to purchase this for $2400 is way lower down on the list of mistakes. The lease for the building we have no staff for is about 1000x the size of that mishap. Though I guess it just means Jane will be let go a year earlier than if that 200K were still here.
I thought it was a rather tame way to address someone who completely fabricated results regarding a test that the US military supposedly did.
Is that how far we have fallen? We don't like people getting called out for making up indications and results?
Is there a bottom rather than what is the bottom?
Stop. There is no conspiracy here. If Brilacidin worked it would be a $10B/year drug like Regeneron's antibody treatment. A big pharma not in the game would have quickly stepped up and bought us for a few billion if they thought it worked. Alternatively they would have partnered us and muscled it through regulatory hurdles.
The obvious answer is Brilacidin isn't very effective against COVID-19 at doses we can give to humans. I'm waiting patiently for the secondary data and CU data that shows Brilacidin's magic but yet another week has passed in silence.
We had our chance. We gambled on a poorly designed trial with our limited funds and lost.
Its time to sell the company. Leo has been unable to move us forward in the last four years. Stock is down over 90% in that time.